Updates in Precision Medicine and Impacts on Clinical Practice with Eric Marsden, ND
1 CE (.25 rx)
Learning Objectives:
Understand when and how to use novel CtDNA assessment in clinical decision making for cancer patients
Understand the utility and limitations for ctDNA as a screening tool for cancer
Understand how biomarkers of stemness on CTCs can influence clinical decision making and evaluation of response
Understand potential non-conventional therapeutic choices for common mutations found in NGS sequencing using ctDNA and tumor genetics
1 CE (.25 rx)
Learning Objectives:
Understand when and how to use novel CtDNA assessment in clinical decision making for cancer patients
Understand the utility and limitations for ctDNA as a screening tool for cancer
Understand how biomarkers of stemness on CTCs can influence clinical decision making and evaluation of response
Understand potential non-conventional therapeutic choices for common mutations found in NGS sequencing using ctDNA and tumor genetics
1 CE (.25 rx)
Learning Objectives:
Understand when and how to use novel CtDNA assessment in clinical decision making for cancer patients
Understand the utility and limitations for ctDNA as a screening tool for cancer
Understand how biomarkers of stemness on CTCs can influence clinical decision making and evaluation of response
Understand potential non-conventional therapeutic choices for common mutations found in NGS sequencing using ctDNA and tumor genetics